Investec raises ICICI Bank stock price target on strong Q4 results

ICICI Bank reported Q4FY26 profit after tax of Rs 137 billion, up 8% year-over-year and 21% quarter-over-quarter, beating estimates by 6% to 11%. Net interest income rose 8% year-over-year, loans grew 16%, and asset quality remained solid with net slippages at 35bps and credit cost at 3bps. Investec raised its target to INR1,625 from INR1,550 and Nomura lifted its target to INR1,620 from INR1,535, both maintaining Buy ratings.

Analysis

The earnings beat is less about one quarter of clean execution and more about ICICI proving it can still compound while the rest of the Indian banking complex likely faces slower deposit beta reset and margin normalization. The key second-order effect is on capital allocation: when a high-quality private bank keeps ROA near elite levels while credit costs stay muted, it can keep paying up for growth in secured retail, rural, and business banking without stressing the balance sheet. That widens the gap versus weaker lenders that need to choose between growth and asset-quality defense.

The market may be underpricing the durability of fee and operating leverage. Fee income softness is the obvious bear case, but the more important tell is that deposit growth is still lagging loan growth, meaning the bank is effectively funding expansion with a slightly tighter liability mix; if that persists for 2-3 quarters, margin stability becomes the main swing factor, not headline loan growth. That is constructive for the stock over months, but it also means the setup is vulnerable to any incremental deposit competition or rate-cut pass-through that compresses NIMs faster than cost saves can offset.

Consensus is likely too focused on the large-cap quality premium and not enough on the next leg of relative performance: if this bank keeps printing low credit costs while peers struggle to match deposit growth, foreign inflows into Indian financials should continue to concentrate here first. The risk is that this becomes a crowded “quality compounder” trade, so the stock can de-rate even on good numbers if management guidance implies normalization rather than acceleration. On a 3-6 month horizon, the main reversal trigger is a pause in loan growth combined with deposit pricing pressure; that would remove the current self-funding growth narrative quickly.

Key Decisions for Investors

• Stay long IBN on a 3-6 month horizon; use pullbacks after earnings revisions to add, with a bias toward buying if the stock de-rates on 'only in-line' fee commentary. Risk/reward remains favorable as long as credit costs stay sub-10 bps and loan growth stays mid-teens.
• Pair trade: long IBN / short a lower-quality Indian private lender basket over the next 1-2 quarters. The thesis is that high-ROA, low-credit-cost banks will continue to attract capital while weaker franchises face funding-pressure-driven margin compression.
• For more asymmetric exposure, buy 6-9 month IBN call spreads rather than outright stock. This captures continued multiple support from earnings resilience while limiting downside if Indian bank valuations compress on macro or rate-cut concerns.
• If IBN rallies hard into the next print, trim 20-30% of the position and re-enter only if deposit growth re-accelerates. The stock is likely to be crowded in momentum/quality screens, which raises the probability of shallow but sharp pullbacks.